Atlas Trials

Study on the Efficacy and Safety of MA-BUCY2 Conditioning in High-risk AML Patients Underwent Haplo-HSCT

Clinical trial NCT05814731 · UNKNOWN

Trial details

NCT number
NCT05814731
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Haploidentical Stem Cell TransplantationConditioning
Start date
2023-04-15
Primary completion
2025-12-31
Enrollment
264

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.